An update on lateral flow immunoassay for the rapid detection of SARS-CoV-2 antibodies
Over the last three years, after the outbreak of the COVID-19 pandemic, an unprecedented number of novel diagnostic tests have been developed. Assays to evaluate the immune response to SARS-CoV-2 have been widely considered as part of the control strategy. The lateral flow immunoassay (LFIA), to det...
| Päätekijät: | , , , , , , |
|---|---|
| Aineistotyyppi: | Artikkeli |
| Kieli: | English |
| Julkaistu: |
AIMS Press
2023-04-01
|
| Sarja: | AIMS Microbiology |
| Aiheet: | |
| Linkit: | https://www.aimspress.com/article/doi/10.3934/microbiol.2023020?viewType=HTML |